Boya Zhang
Tianjin, 300211, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer.
Journal: Cell death & disease
Published: September 28, 2022
Metformin attenuates the epithelial-mesenchymal transition of lens epithelial cells through the AMPK/TGF-β/Smad2/3 signalling pathway.
Journal: Experimental eye research
Published: June 08, 2021
Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC.
Journal: Oncogene
Published: May 31, 2021
TPX2 mediates prostate cancer epithelial-mesenchymal transition through CDK1 regulated phosphorylation of ERK/GSK3β/SNAIL pathway.
Journal: Biochemical and biophysical research communications
Published: January 16, 2021
Restoration of FKBP51 protein promotes the progression of castration resistant prostate cancer.
Journal: Annals of translational medicine
Published: February 12, 2020
YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 19, 2019
LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex.
Journal: Nucleic acids research
Published: May 21, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026